Andreas Koeberle: "Harnessing Lipidomics: Unveiling Innovative Biogenic Agents against Cancer and Inflammation"

3.00 pm

Prof. Dr. Andreas Koeberle, Michael Popp Institute, Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck

"Harnessing Lipidomics: Unveiling Innovative Biogenic Agents against Cancer and  Inflammation"
Seminar series TRR 305 - Striking a moving target: From mechanisms of metastatic organ colonisation to novel systemic therapies

Hybrid (on-site in Erlangen, TRC Auditorium, University of Erlangen) 

Zoom-link, Non-Members of TRR 305 please contact: wencke.wallusch@fau.de